Lanthi-apelin

N/A

Report date: 2025/01/26 19:03:45

Base Information

Drug NameLanthi-apelin
Drug Alias Namelanthionine-stabilized apelin receptor agonist (Lanthio Pharma)lanthionine-stabilized apelin receptor agonist (Lanthio Pharma)LP-7
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionApelin receptor agonists
TargetsApelin receptor
Therapy Area/IndicationsDiabetes MellitusHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLanthio Pharma Bv
China Registration ClassN/A

Develop Information

Active CompaniesLanthio Pharma Bv
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A